Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jumia Technologies AG - ADR (JMIA) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Jumia Technologies AG - ADRTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Jumia Technologies AG - ADR vs DENTSPLY SIRONA Inc — how do they compare? Jumia Technologies AG - ADR trades at $6.23 (market cap $719.58M), while DENTSPLY SIRONA Inc trades at $11.36 (market cap $2.31B). The key difference: DENTSPLY SIRONA Inc is far larger — about 3.2× Jumia Technologies AG - ADR's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals.

JMIAXRAY
Market Cap
$719.58M$2.31B
Sector
Consumer CyclicalHealth
52-Week High
$14.60$14.68
52-Week Low
$5.69$9.64
Enterprise Value
$666.68M$4.39B
Dividend Yield
5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jumia Technologies AG - ADR

JMIA trades at $6.245, up 4.08% on the day, amid a bearish technical signal and mixed fundamentals. The company reported revenue of $188.93M for 2025 with a gross profit margin of 54.75%, but net losses persist, and recent earnings have missed expectations. Analyst consensus is strongly bullish with 71.43% buy ratings, while technical indicators show selling pressure.

The outlook hinges on JMIA's path to profitability, targeting Q4 2026 breakeven and 2027 profitability. Risks include high cash burn and competitive pressures, but gross profit growth and strategic partnerships offer potential upside for patient investors focused on the African e-commerce market.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $11.40, down 2.23% amid ongoing revenue declines and negative profitability. The stock shows bearish technical signals with support at $11 and resistance at $12. Recent Q2 2026 earnings beat expectations with $0.52 EPS but revenue fell 4.1% year-over-year to $898 million, reflecting persistent challenges in dental markets. The company maintains a 'Hold' analyst consensus with a $11.50 price target while executing its turnaround strategy.

Investment outlook remains cautious given six consecutive quarters of revenue declines and negative net margins. The company's restructuring efforts and new CFO appointment offer potential for operational improvement, but weak European demand and competitive pressures pose significant headwinds. With debt-to-asset ratio rising to 42.88% in 2025, financial leverage adds risk to the recovery thesis.

Returns comparison

Trailing returns across standard periods

About Jumia Technologies AG - ADR

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.

Read more on JMIA

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY